Does an initial strategy of PCI plus medical therapy improve survival in patients with stable ischemic heart disease compared to medical therapy alone?
An initial strategy of PCI added to medical therapy does not confer a long-term survival advantage over medical therapy alone in patients with stable ischemic heart disease.
During an extended-follow-up of up to 15 years, we did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease. (Funded by the VA Cooperative Studies Program and others; COURAGE ClinicalTrials.gov number, NCT00007657.).
Sedlis et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: